COMMUNIQUÉS West-GlobeNewswire

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
22/04/2026
160-participant, triple-blinded, sham-controlled study designed to support planned De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq [...]
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
22/04/2026
Demonstration batch production achieves all prespecified test specifications for dissolution, content uniformity, blend uniformity meeting regulatory requirements to start clinical drug product production GLEN ALLEN, Va [...]
LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer
22/04/2026
Neutrophils, long considered short-lived immune cells, can be therapeutically targeted when their appropriate subset and functional state are identified for the disease context LIfT BioSciences’ immunomodulatory alpha [...]
PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report
22/04/2026
Following recognition as highest in execution and furthest in vision in the 2026 Magic Quadrant™ for Clinical Communication and Collaboration MIAMI, April 22, 2026 (GLOBE NEWSWIRE) -- PerfectServe®, a leading provider [...]
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
22/04/2026
April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: [...]
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
22/04/2026
Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient access ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator [...]
Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina
22/04/2026
The collaboration expands access to comprehensive outpatient behavioral health services for individuals with SMI in Mecklenburg County CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Amae Health, a leader in [...]
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
22/04/2026
SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced the [...]
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
22/04/2026
Searchable in Seconds Powered by Palantir Foundry MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of [...]
EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers
22/04/2026
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- EmblemHealth, one of the nation’s largest not-for-profit health plans, today announced the citywide expansion of its Community Diabetes Wellness Program . Originally launched [...]
Eleos Expands AI Agents Across the Full Care Journey
22/04/2026
New capabilities support provider decision-making, resolve eligibility gaps, and surface compliance risks the moment they can change outcomes DENVER and BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Eleos, the system of [...]
Astiva Health Entered April 2026 with Record High 47,000+ Enrolled Members
22/04/2026
ORANGE, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Astiva Health (“Astiva” or the “Company”), a rapidly growing Medicare Advantage organization serving California’s diverse senior population, today announced another [...]
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
22/04/2026
NORWOOD, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on promising new therapies in oncology and obesity, today announced that updated [...]
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
22/04/2026
Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of Hematology (ASH) Annual [...]
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
22/04/2026
MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March [...]
Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026
22/04/2026
MKIs uniquely block multiple receptor tyrosine kinases (RTKs) simultaneously, addressing the inflammatory, vascular, and fibrotic causes of serious, underserved front-of-the-eye diseases Lead MKI candidates, CBT-001 and [...]
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
22/04/2026
SYDNEY, AUSTRALIA, April 22, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today [...]
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
22/04/2026
Members of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Represent the Largest Addressable User Market for the LIBERTY System At least [...]
Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting
22/04/2026
- UNILATERAL MTLE: Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy evaluation period (N=9), and 100% median disabling seizure reduction in [...]

Pages